Cardiometabolic Health Congress
Cardiometabolic Health Congress
October 26, 2018
3 min watch
Save

VIDEO: Determination often required to obtain PCSK9 inhibitors for appropriate patients

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

BOSTON — In this video exclusive, Matthew Stryker, PharmD, a clinical pharmacist who runs a free cardiovascular risk reduction service at a clinic in Albany, New York, and is a stakeholder in The Doctor-Patient Rights Project, relates a personal story of seeking prior authorization for the PCSK9 inhibitor alirocumab for a statin-intolerant patient with familial hypercholesterolemia.

Only after a fourth appeal with a federal appeals judge was the patient able to obtain the medication. Stryker describes additional resources for prescribers in the appeals process after receiving denial of an original request.